TNIK
protein-codingTRAF2 and NCK interacting kinase, the group of MicroRNA protein coding host genes
Gene summary
Wnt signaling plays important roles in carcinogenesis and embryonic development. The protein encoded by this gene is a serine/threonine kinase that functions as an activator of the Wnt signaling pathway. Mutations in this gene are associated with an autosomal recessive form of cognitive disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~402.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0014876
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014876
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019502
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014876
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0000509
Submitter: ClinGen
*TNIK* encodes the TRAF2 and NCK-interacting protein kinase involved in dendrite development and synaptic transmission. *TNIK* was first reported in relation to autosomal recessive non-syndromic intellectual disability in 2016 (Anazi et al., PMID: 27106596). A homozygous nonsense variant (p.Arg180*) was reported in two multiplex, consanguineous Saudi Arabian families with five affected males, and was determined to be a founder variant. Affected individuals exhibit intellectual disability, speech delay, and hyperactivity. Western blot analysis of patient cells showed absence of the TNIK protein. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by experimental evidence, including functional alterations in human cells, and a mouse model. TNIK functions as a postsynaptic density (PSD) signaling hub, and *TNIK* mutations in hiPSC-derived excitatory neurons have been shown to disrupt immature synapse function and impair MAPK-dependent phosphorylation of core PSD proteins (PMID: 38638602). *Tnik* knock-out mice show impairments in dentate gyrus neurogenesis, cognitive deficits, and hyperlocomotor behavior (PMID: 23035106). In summary, there is limited evidence supporting the relationship between *TNIK* and autosomal recessive non-syndromic intellectual disability. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. The classification was downgraded from moderate to limited because only two families with the same founder variant have been reported since 2016. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 6, 2025 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0014876
Submitter: Illumina
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TNIK variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015028.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 38 | 2 | 46 | ||
| missense | 140 | 2 | 142 | |||
| nonsense | 1 | 4 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 1 | 0 | 161 | 40 | 2 | 204 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055843.1 | 33 | MANE Select | |
| Ensembl | ENSP00000399511.2 | 33 | MANE Select | |
| RefSeq | NP_001155032.1 | 32 | Standard | |
| RefSeq | NP_001155033.1 | 32 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tnika | Danio rerio | Structure: EVL Quality: structure abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oxidative Stress Induced Senescence
- Oxidative Stress Induced Senescence
- Cellular Senescence
- Cellular responses to stress
- Cellular responses to external stimuli
Biological Process
- MAPK cascade
- positive regulation of protein phosphorylation
- protein phosphorylation
- cytoskeleton organization
- activation of JNKK activity
Molecular Function
- protein kinase activity
- protein serine/threonine kinase activity
- protein binding
- ATP binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- cytoskeleton
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000436636
- Coding exons
- 33
- Length
- 399070
- Individuals with no LoFs
- 124696
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 13
- Defined
- 124709
- p
- 0.0000521
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.10 | 436 | 753 | 0.579 | 0.0000427 | 8865 |
| Missense (PolyPhen) | 160 | 294.46 | 0.54336 | 3558 | ||
| Synonymous | 0.423 | 262 | 271 | 0.967 | 0.0000148 | 2555 |
| Loss of Function | 7.75 | 9 | 87.0 | 0.103 | 0.00000533 | 945 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000088 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000072 | 0.000071 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:19061864, ECO:0000269|PubMed:19816403, ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:21690388}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 54 (MRT54) [MIM:617028]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT54 patients manifest intellectual disability, delayed speech and hyperactivity. {ECO:0000269|PubMed:27106596}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- LoFtool
- 0.467
- RVIS EVS
- -1.44
- RVIS percentile EVS
- 3.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.978
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |